Orgalime NLF interpretative fiche - Transitional DoC arrangements

Published: 2 July 2014

Policies & Issues: Internal Market - Compliance, Standards & Enforcement

Orgalime requests the European Commission to allow for pragmatic solutions to the question of which Directives should manufacturers indicate on Declarations of Conformity (DoC) issued during the transposition period.
This is the period starting from the date of entry into force of the revised Directive (new Directive) and ending with the date of repeal of the existing Directive (old Directive), that is until 19 April 2016.
Such pragmatic solutions are necessary after the alignment of Directives with the New Legislative Framework. This alignment led to a change of the Directives’ numbering, but without any changes to their essential requirements. Nevertheless, the Directives’ provisions for the transitional period do not contain any statements regarding the version(s) of the Directive(s) to be referenced in the Declarations of Conformity (DoC).

Related Position Papers

Internal Market: Joint Industry recommendations for effective Harmonised Standardisation [6 July 2021]

Internal Market: Joint open letter on industry competitiveness and EU standardisation [1 February 2021]

Internal Market: Orgalim comments on the NLF evaluation roadmap [2 December 2020]

Internal Market: Orgalim comments on the 2020 draft Blue Guide [13 November 2020]

Internal Market: Orgalim comments on the Draft Guidelines for the practical implementation of Article 4 of Regulation 2019/1020 on market surveillance and compliance of products [22 April 2020]

Internal Market: Shaping a New Deal for the Single Market: Harmonised standards in support of a competitive European industry [27 January 2020]

Internal Market: Suggestions for a revision of the Blue Guide on the implementation of EU product rules 2016 [27 January 2020]

Internal Market: For a restored mutual trust in a market-relevant European Standardisation System [24 September 2019]

Towards effective, efficient EU market surveillance: all for a level-playing field without additional burdens for legitimate manufacturers [6 December 2018]